Global Influenza Vaccines Market worth USD 4.34 Billion in 2021 Global Influenza Vaccines Market worth USD 4.34 Bi | Page 2

Based on Vaccine Type, Quadrivalent Vaccines is projected to be the fastest
growing segment
The specificity as well as the effectiveness of quadrivalent influenza vaccines
and increasing consumer demand for quadrivalent flu vaccines are the key
factors propelling the growth of quadrivalent flu vaccines market. Quadrivalent
flu vaccines provides protection against four strains of influenza viruses. These
include Quadrivalent flu shots which are used diverse age groups. Intradermal
Quadrivalent flu shot and Quadrivalent flu shot are the two major types having
virus grown in cell culture. The growing baby boomer population is also an
important factor which will fuel the growth of the said market during the
forecast period.
Based on Route of Administration, Intramuscular flu vaccines segment is
estimated to hold the largest market share in the influenza vaccines market
The intramuscular flu vaccines segment is estimated to capture the largest
share of the total influenza vaccines market due to the increased demand for
these vaccines globally. There has been increasing participation of countries to
get vaccinated intramuscularly to avoid side effects and complications
associated with other routes of administration.
Asia-Pacific is expected to witness a substantial growth in the influenza
vaccines market during the forecast period
The high demand for seasonal and pandemic influenza vaccines in Asia-Pacific
countries (for example India, China, Japan, Australia etc.) primarily prompted
during influenza A/H1N1 (swine flu) pandemic. Also, with the strong demand for
domestic flu vaccines and the government’s stepped-up support, the
development and production of flu vaccines is poised to be a new growth area
for emerging countries drug makers, especially major companies with larger
production capacity. The influenza vaccines market is expected to register
further growth in the emerging economies such as India and China.
For more details, browse the Table of
Contents: https://www.gmiresearch.com/report/influenza-vaccines-market-
vaccine-type-quadrivalent-trivalent.html
About GMI Research
GMI Research is a market research and consulting firm which provides research-
based solutions to business executives and investment professionals so that
they can make right business & investment decisions faster based on real facts.
We help business leaders through independent fact-based insight, ensuring their
business achieve success by beating the competition.